<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04172649</url>
  </required_header>
  <id_info>
    <org_study_id>AcuPro 09.2019</org_study_id>
    <secondary_id>DRK S00019884</secondary_id>
    <nct_id>NCT04172649</nct_id>
  </id_info>
  <brief_title>Acupuncture With Press Tack Needles for Perioperative Pain After Open Radical Prostatectomy</brief_title>
  <acronym>AcuPro</acronym>
  <official_title>A Randomized Controlled Study on Acupuncture for Perioperative Pain After Open Radical Prostatectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Martini-Klinik am UKE GmbH</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Seirin Corporation, Shizuoka City, Japan</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Martini-Klinik am UKE GmbH</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Acupuncture has been shown in several meta-analyses and clinical studies, in different&#xD;
      surgical settings and chronic back pain, to be a safe adjuvant option for postoperative pain&#xD;
      treatment. In this study, the investigator hypothesize that acupuncture can decrease&#xD;
      postoperative pain intensity and amount of given analgesics, and accelerate recovery of bowel&#xD;
      motility, in patients after open radical prostatectomy.&#xD;
&#xD;
      The investigator will also investigate whether or not acupuncture with needle skin&#xD;
      penetration is more efficacious than acupressure.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will be a randomized, controlled and partially blinded study with three arms: 1)&#xD;
      press tack needle acupuncture (ACU) and routine postoperative analgesic care, 2) press tack&#xD;
      placebo acupressure (SHAM) and routine postoperative analgesic care, and 3) only routine&#xD;
      postoperative analgesic care (CONTROL).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">March 1, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Actual">April 9, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative pain intensity measured by Numeric Rating Scale (NRS-11)</measure>
    <time_frame>postoperative day three</time_frame>
    <description>The primary outcome is to check the effects of permanent needle acupuncture at 6 acupuncture points for changing postoperative pain intensity as measured by the Numeric Rating Scale (NRS-11), calculated as area under the curve (AUC).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cumulative use (sum in mg) of routine postoperative analgesics</measure>
    <time_frame>postoperative day three</time_frame>
    <description>Cumulative use (sum in mg) of routine postoperative analgesics</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to first defecation following surgery</measure>
    <time_frame>postoperative day three</time_frame>
    <description>Time to first defecation following surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>EQ-5D-5L for quality of life</measure>
    <time_frame>7 days after catheter removal</time_frame>
    <description>fill out a questionnaire: According to the website httpp://euroqol.org/eq-5d-instruments/eq-5d-5l-about/ under the tab &quot;User guide 5L&quot;, page 5 in a blue box, it states that EQ-5D-5L is not an abbreviation and should be used and quoted as is. The EQ-5D-5L questionnaire measures quality of life based on 5 different levels (no problems, slight problems, moderate problems, severe problems and extreme problems) to each of the following dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">126</enrollment>
  <condition>Prostate Cancer</condition>
  <condition>Perioperative Pain</condition>
  <arm_group>
    <arm_group_label>Acu Arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>press tack needle acupuncture (ACU) and routine postoperative analgesic care</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SHAM Arm</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>press tack placebo acupressure (SHAM) and routine postoperative analgesic care</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CONTROL Arm</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients in the control group will receive only routine postoperative analgesic care</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Acupuncture</intervention_name>
    <description>On the day before surgery, patients randomized to the intervention groups will receive routine postoperative analgesic care with application of 6 bilateral press tack needles (diameter of 0.15mm and length of 0.6mm for P-6 and Shenmen, diameter of 0.20mm and length of 1.2mm for SP-6, Seirin New Pyonex, Seirin Corp., Shizuoka City, Japan).</description>
    <arm_group_label>Acu Arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Acupressure</intervention_name>
    <description>On the day before surgery, patients randomized to the intervention groups will receive routine postoperative analgesic care with application of 6 bilateral press tack placebos (knob without needle, diameter of 0.15mm and length of 0.6mm for P-6 and Shenmen, diameter of 0.20mm and length of 1.2mm for SP-6, Seirin New Pyonex, Seirin Corp., Shizuoka City, Japan).</description>
    <arm_group_label>SHAM Arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Males aged 18-70 years&#xD;
&#xD;
          -  Diagnosis with prostate cancer and scheduled for open radical prostatectomy&#xD;
&#xD;
          -  Ability and willingness to follow study instructions and complete all required&#xD;
             questionnaires during hospitalization and follow-up&#xD;
&#xD;
          -  Written informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Inability to understand the terms of this study&#xD;
&#xD;
          -  Simultanously participation in other clinical trials possibly influencing primary or&#xD;
             secondary endpoints or any acupuncture-related clinical trials within 30 days prior to&#xD;
             inclusion&#xD;
&#xD;
               -  Prior surgery within the last three months&#xD;
&#xD;
               -  Received acupuncture within 6 weeks before surgery&#xD;
&#xD;
               -  Known hypersensitivity or fear of acupuncture&#xD;
&#xD;
               -  Known abuse of drugs, medications and alcohol&#xD;
&#xD;
               -  Chronic pain for more than 3 months&#xD;
&#xD;
               -  Continuous opioid analgesic medications for more than 3 days during the 4 weeks&#xD;
                  prior to surgery&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Prostate cancer</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hans Heinzer, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vice Medical Director and Faculty member of Martini-Klinik</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Martini-Klinik am UKE GmbH</name>
      <address>
        <city>Hamburg</city>
        <zip>20246</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>November 13, 2019</study_first_submitted>
  <study_first_submitted_qc>November 20, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 21, 2019</study_first_posted>
  <last_update_submitted>April 14, 2021</last_update_submitted>
  <last_update_submitted_qc>April 14, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>prostate cancer</keyword>
  <keyword>pain management</keyword>
  <keyword>acupuncture</keyword>
  <keyword>acupressure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prostatic Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>November 20, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/49/NCT04172649/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

